PRI-VENT
Internal Medicine
Nephrology
Kidney Disease
Kidney Transplant
Focal Segmental Glomerulosclerosis
Pediatric Subjects
Adult Subjects
Female Subjects
Male Subjects
This is a pilot/feasibility, multicenter, randomized, open label, clinical trial to test that hypothesis that plasmapheresis plus rituximab prior to or at the time of kidney transplantation can prevent recurrent FSGS in children and adults.